Measles outbreak in Northern Central African Republic 3 years after the last national immunization campaign

BMC Infectious Diseases

Volumn 13, Issue 1, 2013, Pages

  Tricou, Vianney ^a   Pagonendji, Marilou ^a   Manengu, Casimir ^b   Mutombo, Jeff ^c   Mabo, Rock Ouambita ^d   Gouandjika Vasilache, Ionela ^a  

^a INSTITUT PASTEUR DE BANGUI   (Central African Republic)

^b WHO Office   (Central African Republic)

^c MÉDECINS SANS FRONTIÈRES   (Switzerland)

^d De la Population et de la Lutte contre le SIDA   (Central African Republic)

Author keywords

Central African Republic; Measles; Outbreak; Supplementary immunization activities

Indexed keywords

IMMUNOGLOBULIN M ANTIBODY; MEASLES VACCINE;

ADOLESCENT; AGE DISTRIBUTION; ARTICLE; CENTRAL AFRICAN REPUBLIC; CHILD; EPIDEMIC; FEMALE; GENOTYPE; HEALTH PROGRAM; HUMAN; MAJOR CLINICAL STUDY; MALE; MEASLES; MEASLES VACCINATION; MEASLES VIRUS; MORTALITY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRESCHOOL CHILD; SCHOOL CHILD; TREATMENT OUTCOME;

ADOLESCENT; ANTIBODIES, VIRAL; CENTRAL AFRICAN REPUBLIC; CHILD; CHILD, PRESCHOOL; DISEASE OUTBREAKS; HUMANS; IMMUNOGLOBULIN M; INFANT; MASS VACCINATION; MEASLES; MEASLES VACCINE; PHYLOGENY;

EID: 84874209523     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-13-103     Document Type: Article

References (16)

1. Perry RT, Halsey NA. The clinical significance of measles: a review. J Infect Dis 2004, 189(Suppl 1):S4-16.
2. CDC Progress in Global Measles Control, 2000-2010. MMWR Morb Mortal Wkly Rep 2012, 61(04):73-78. CDC.
3. CDC Progress toward measles control - African region, 2001-2008. MMWR Morb Mortal Wkly Rep 2009, 58(37):1036-1041. CDC.
4. Halsey NA. Measles in developing countries. BMJ 2006, 333(7581):1234. 10.1136/bmj.39058.361620.BE, 1702417, 17170396.
5. CDC Increased transmission and outbreaks of measles - European Region, 2011. MMWR Morb Mortal Wkly Rep 2011, 60(47):1605-1610. CDC.
6. Measles reported cases http://apps.who.int/immunization_monitoring/en/globalsummary/timeseries/tsincidencemea.htm.
7. WHO-UNICEF estimates of national immunization coverage http://apps.who.int/immunization_monitoring/en/globalsummary/wucoveragecountrylist.cfm.
8. WHO Monitoring progress towards measles elimination. Wkly Epidemiol Rec 2010, 85(49):490-494. WHO.
9. WHO New genotype of measles virus and update on global distribution of measles genotypes. Wkly Epidemiol Rec 2005, 80(40)):347-351. WHO.
10. Kremer JR, Fack F, Olinger CM, Mulders MN, Muller CP. Measles virus genotyping by nucleotide-specific multiplex PCR. J Clin Microbiol 2004, 42(7):3017-3022. 10.1128/JCM.42.7.3017-3022.2004, 446258, 15243053.
11. Tamura K, Peterson D, Peterson N, Stecher G, Nei M, Kumar S. MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol 2011, 28(10):2731-2739. 10.1093/molbev/msr121, 3203626, 21546353.
12. Gouandjika-Vasilache I, Waku-Kouomou D, Ménard D, Beyrand C, Guye F, Ngoay-Kossy JC, Sélekon B, Wild TF. Cocirculation of measles virus genotype B2 and B3.1 in Central African Republic during the 2000 measles epidemic. J Med Virol 2006, 78(7):964-970. 10.1002/jmv.20648, 16721862.
13. Siegfried N, Wiysonge CH, Pienaar D. Too little, too late; measles epidemic in South Africa. Lancet 2010, 376(9736):160-160.
14. The International Federation of Red Cross and Red Crescent Societies http://www.ifrc.org/en/news-and-media/press-releases/africa/chad/chad-red-cross-red-crescent-strengthens-its-activities-in-areas-hit-by-meningitis-measles-and-cholera/, The International Federation of Red Cross and Red Crescent Societies.
15. The Central Emergency Response Fund http://www.unocha.org/cerf/cerf-worldwide/where-we-work/2011/tcd-2011, The Central Emergency Response Fund.
16. WHO Measles vaccines: WHO position paper. Wkly Epidemiol Rec 2009, 84(35):349-360. WHO.